3D Bioprinting Industry The global 3D bioprinting market size is expected to reach USD 5.3 billion by 2030, expanding at a CAGR of 12.5% over the forecast period, according to a new report by Grand View Research, Inc. Rising cases of COVID-19 and high prevalence of chronic diseases are some of the major factors contributing to the growth. During the outbreak of the pandemic, 3D...

According to the research report, the global hospital capacity management solutions market was valued at USD 3,588.42 million in 2022 and is expected to reach USD 16,980.74 million by 2032, to grow at a CAGR of 17.0% during the forecast period. This growth is being catalyzed by increasing patient admissions, healthcare digitization, and the rising pressure on hospitals to maximize...

Market Overview: The global diabetic neuropathy treatment market is poised for substantial growth in the coming years, driven by the increasing prevalence of diabetes, advancements in drug development, and growing awareness about nerve-related complications associated with chronic hyperglycemia. Diabetic neuropathy, a type of nerve damage that affects people with diabetes, is among...

According to a recent report by Grand View Research, Inc., the global 3D bioprinting market is projected to reach a value of USD 5.3 billion by 2030, demonstrating a robust compound annual growth rate (CAGR) of 12.5% throughout the forecast period. This significant market expansion is largely driven by several key factors, including the rising incidence of COVID-19 cases and the high...